日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial

基于风险的乳腺癌筛查与年度筛查:WISDOM随机临床试验

Esserman, Laura J; Fiscalini, Allison S; Naeim, Arash; Van't Veer, Laura J; Kaster, Andrea; Scheuner, Maren T; LaCroix, Andrea Z; Borowsky, Alexander D; Anton-Culver, Hoda; Olopade, Olufunmilayo I; Esserman, James; Lancaster, Rachael; Madlensky, Lisa; Blanco, Amie M; Ross, Katherine S; Goodman, Deborah L; Tong, Barry S; Hogarth, Michael; Heditsian, Diane; Brain, Susie; Lee, Vivian; Blum, Kelly; Kim, Mi-Ok; Sabacan, Leah P; Fergus, Kirkpatrick B; Yau, Christina; Park, Hannah L; Parker, Barbara A; Kaplan, Celia; Rhoads, Kim F; Eder, Suzanne; Adduci, Kelly; Matthews, Jeffrey B; Wenger, Neil S; Shieh, Yiwey; Hiatt, Robert A; Ziv, Elad; Tice, Jeffrey A; Eklund, Martin

Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial

无乳腺癌病史女性的生殖系致病变异:WISDOM随机临床试验的二次分析

Fergus, Kirkpatrick B; Ross, Katherine S; Scheuner, Maren T; Blanco, Amie M; Tice, Jeffrey A; Ziv, Elad; Shieh, Yiwey; van 't Veer, Laura; Olopade, Olufunmilayo I; Goodman, Deborah L; Tong, Barry S; Harvey, Heather; DeRosa, Diana; Risty, Larissa; Silver, Erica; Kaster, Andrea; Fiscalini, Allison Stover; Blum, Kelly; Heise, Rachel; Sabacan, Leah; Heditsian, Diane; Brain, Susie; Petruse, Antonia; Eklund, Martin; Hiatt, Robert A; Borowsky, Alexander D; Naeim, Arash; Park, Hannah L; LaCroix, Andrea Z; Parker, Barbara A; Lancaster, Rachael; Esserman, James; Wenger, Neil; Arasu, Vignesh; Anton-Culver, Hoda; Esserman, Laura J; Madlensky, Lisa

The Hallmarks of Predictive Oncology

预测肿瘤学的标志

Singhal, Akshat; Zhao, Xiaoyu; Wall, Patrick; So, Emily; Calderini, Guido; Partin, Alexander; Koussa, Natasha; Vasanthakumari, Priyanka; Narykov, Oleksandr; Zhu, Yitan; Jones, Sara E; Abbas-Aghababazadeh, Farnoosh; Kadambat Nair, Sisira; Bélisle-Pipon, Jean-Christophe; Jayaram, Athmeya; Parker, Barbara A; Yeung, Kay T; Griffiths, Jason I; Weil, Ryan; Nath, Aritro; Haibe-Kains, Benjamin; Ideker, Trey

WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design

WISDOM随机试验比较基于风险的乳腺癌筛查与年度筛查:研究队列特征和设计

Fiscalini, Allison; Blum, Kelly; Fergus, Kirkpatrick; Hiatt, Robert A; Naeim, Arash; Kaster, Andrea; Scheuner, Maren T; van 't Veer, Laura J; LaCroix, Andrea Z; Borowsky, Alexander D; Olopade, Olufunmilayo I; Park, Hannah L; Esserman, James; Lancaster, Rachael; Heditsian, Diane; Brain, Susie; Lee, Vivian; Goodman, Deborah L; Ross, Katherine S; Wenger, Neil; Parker, Barbara A; Madlensky, Lisa; Tice, Jeffrey A; Shieh, Yiwey; Ziv, Elad; Arasu, Vignesh A; Anton-Culver, Hoda; Kaplan, Celia P; Rhoads, Kim F; Badal, Kimberly; Hogarth, Michael; Petruse, Antonia; Soto, Irene A; Leggat-Barr, Katherine; Goodman, Steffanie; Atamer, Jennifer; Ryu, Rita; Adduci, Kelly; Matthews, Jeffrey B; Eklund, Martin; Sabacan, Leah P; Esserman, Laura

A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer

一项针对局部晚期/不可切除或转移性Her2阴性乳腺癌的zilovertamab联合紫杉醇的1b期研究

Shatsky, Rebecca A; Batra-Sharma, Hemali; Helsten, Teresa; Schwab, Richard B; Pittman, Emily I; Pu, Minya; Weihe, Elizabeth; Ghia, Emanuela M; Rassenti, Laura Z; Molinolo, Alfredo; Cabrera, Betty; Breitmeyer, James B; Widhopf, George F 2nd; Messer, Karen; Jamieson, Catriona; Kipps, Thomas J; Parker, Barbara A

Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer

更正:一项针对局部晚期/不可切除或转移性HER2阴性乳腺癌的zilovertamab联合紫杉醇的1b期研究

Shatsky, Rebecca A; Batra-Sharma, Hemali; Helsten, Teresa; Schwab, Richard B; Pittman, Emily I; Pu, Minya; Weihe, Elizabeth; Ghia, Emanuela M; Rassenti, Laura Z; Molinolo, Alfredo; Cabrera, Betty; Breitmeyer, James B; Widhopf Ii, George F; Messer, Karen; Jamieson, Catriona; Kipps, Thomas J; Parker, Barbara A

Relationship of physical activity and cognitive functioning among breast cancer survivors: a cross-sectional analysis

乳腺癌幸存者身体活动与认知功能的关系:一项横断面分析

Hartman, Sheri J; Zablocki, Rong W; Tam, Rowena M; Palmer, Barton W; Parker, Barbara A; Sears, Dorothy D; Ahles, Tim A; Natarajan, Loki

The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer

口服选择性雌激素受体降解剂 GDC-0810 (ARN-810) 用于治疗绝经后激素受体阳性/HER2阴性 (HR+/HER2-) 晚期/转移性乳腺癌

Bardia, Aditya; Mayer, Ingrid; Winer, Eric; Linden, Hannah M; Ma, Cynthia X; Parker, Barbara A; Bellet, Meritxell; Arteaga, Carlos L; Cheeti, Sravanthi; Gates, Mary; Chang, Ching-Wei; Fredrickson, Jill; Spoerke, Jill M; Moore, Heather M; Giltnane, Jennifer; Friedman, Lori S; Chow Maneval, Edna; Chan, Iris; Jhaveri, Komal

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial

I-SPY2新辅助乳腺癌试验中基线ROR1和ROR2基因表达与临床结果的相关性

Parker, Barbara A; Shatsky, Rebecca A; Schwab, Richard B; Wallace, Anne M; Wolf, Denise M; Hirst, Gillian L; Brown-Swigart, Lamorna; Esserman, Laura J; van 't Veer, Laura J; Ghia, Emanuela M; Yau, Christina; Kipps, Thomas J

Preventing Sleep Disruption With Bright Light Therapy During Chemotherapy for Breast Cancer: A Phase II Randomized Controlled Trial

利用强光疗法预防乳腺癌化疗期间睡眠紊乱:一项II期随机对照试验

Rissling, Michelle; Liu, Lianqi; Youngstedt, Shawn D; Trofimenko, Vera; Natarajan, Loki; Neikrug, Ariel B; Jeste, Neelum; Parker, Barbara A; Ancoli-Israel, Sonia